Vittorio Iorno

Suggest Changes
Learn More
CONTEXT Neuropathic pain is common, disabling, and often difficult to treat. OBJECTIVES To compare guideline-based drug management with Scrambler therapy, a patient-specific electrocutaneous nerve(More)
BACKGROUND Guidelines tend to consider morphine and morphine-like opioids comparable and interchangeable in the treatment of chronic cancer pain, but individual responses can vary. This study(More)
PURPOSE Neuropathic pain is commonly associated with cancer. Current treatments include combination opioid and adjuvant therapies, but no guidelines are available for dose escalation strategies. This(More)
9028 Background: The rate of neuropathic pain (NP) control with single agents is low. Oxycodone and pregabalin alone have proven activity in NP, but controlled data on their rational combination is(More)